Most Clicked DiabetesPro SmartBrief Stories


1. Dexcom gains FDA approval for wireless glucose monitoring device

DiabetesPro SmartBrief | Oct 21, 2014

The FDA gave pre-market approval for the Dexcom Share device, which wirelessly transmits data from the company's G4 Platinum continuous glucose monitor to designated smartphones as part of a remote glucose monitoring system. MassDevice.com (Boston) (10/20)


2. Enterovirus infection linked to type 1 diabetes risk in children

DiabetesPro SmartBrief | Oct 20, 2014

Children infected with enterovirus were about 50% more likely to develop type 1 diabetes compared with uninfected children, Taiwanese researchers wrote in the journal Diabetologia. Older age at infection diagnosis was associated with a greater likelihood of diabetes, the researchers said. Science World Report (10/19)


3. Study: High-intensity statins may slow diabetic coronary atherosclerosis

DiabetesPro SmartBrief | Oct 22, 2014

Researchers at the Cleveland Clinic found high-intensity statin treatment was associated with coronary atheroma regression in patients with or without diabetes, suggesting the therapy may halt the progression of diabetic coronary atherosclerosis. The findings appear in Diabetes Care. PhysiciansBriefing.com (10/21)


4. Men with diabetes, low testosterone show higher heart risks

DiabetesPro SmartBrief | Oct 17, 2014

Data on 115 male type 2 diabetes patients showed those with low testosterone levels were six times as likely to suffer increased carotid thickness and endothelium dysfunction than those who had normal testosterone. The results were published in The Journal of Clinical Endocrinology & Metabolism. DailyRx.com (10/16)


5. Trial underway for Medtronic's Predictive Low Glucose Management tech

DiabetesPro SmartBrief | Oct 21, 2014

Medtronic has begun patient enrollment in a clinical study of its Predictive Low Glucose Management system, which combines a continuous glucose monitor and an advanced insulin pump into a single unit. The study, which will involve 84 participants from as many as eight U.S. clinical sites, will test whether the device is safe and effective in helping control hypoglycemia and rebound hyperglycemia. Healio (free registration) (10/18)


6. Diabetes patients show poor response to stress

DiabetesPro SmartBrief | Oct 22, 2014

Type 2 diabetes patients exhibited an impaired ability to regulate blood pressure, cholesterol and heart rate when they experience stress, a study in PNAS indicated. Researchers also noted increased depressive and hostile symptoms in these patients. Business Insider (10/21)


7. Novo's Saxenda may gain FDA nod by year's end, analysts say

DiabetesPro SmartBrief | Oct 22, 2014

Although an expected decision did not come on Monday, analysts from Citi, Nordea and Sydbank all agreed that Danish drug firm Novo Nordisk will likely gain FDA approval for its anti-obesity drug liraglutide by the end of the year. The drug will be labeled Saxenda and it will be launched in 2015 should it obtain approval. Reuters (10/21)


8. Regular sugary soda consumption linked to accelerated cell aging

DiabetesPro SmartBrief | Oct 21, 2014

Adults who drank an average of one 20-ounce sugary soda per day had 4.6 years of additional biological aging due to shorter telomeres within white blood cells, an impact similar to that of smoking, according to a study in the American Journal of Public Health. MedicalDaily.com (10/20)


9. Lorcaserin boosts weight loss, metabolic markers in obese

DiabetesPro SmartBrief | Oct 17, 2014

Overweight and obese patients who took lorcaserin as an adjunct to diet and exercise attained greater weight loss and significant improvements in cardiometabolic markers and quality of life compared with those in the placebo group, researchers reported in Postgraduate Medicine. Healio (free registration) (10/15)


10. Gut microbe rhythm tied to circadian clock

DiabetesPro SmartBrief | Oct 20, 2014

Gut microbes in mice and humans have circadian rhythms that are controlled by the biological clock of the host in which they reside. Disruption of the circadian clock in the host alters the rhythm of the gut microbes, potentially leading to obesity and metabolic problems, which may help explain why shift workers and people with frequent jet lag gain extra weight, according to the study in the journal Cell. HealthDay News (10/16)




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more